By Abigail Townsend
Date: Monday 22 Sep 2025
(Sharecast News) - Pfizer Inc has agreed to buy biotech Metsera in multi-billion dollar deal, the US drugs giant confirmed on Monday, giving it a foothold in the booming weight-loss sector and sending shares in the start-up soaring.
Currency | US Dollars |
Share Price | $ 839.87 |
Change Today | $ 20.02 |
% Change | 2.44 % |
52 Week High | $932.06 |
52 Week Low | $625.65 |
Volume | 5,088,509 |
Shares Issued | 948.17m |
Market Cap | $796,340m |
Beta | 0.69 |
RiskGrade | 179 |
Strong Buy | 11 |
Buy | 10 |
Neutral | 8 |
Sell | 0 |
Strong Sell | 0 |
Total | 29 |
Time | Volume / Share Price |
15:51 | 100 @ $840.73 |
15:51 | 137 @ $840.73 |
15:50 | 100 @ $841.22 |
15:50 | 100 @ $841.52 |
15:50 | 100 @ $841.48 |
You are here: research